Health CanadaGeneral Alert
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely...
Published: October 18, 2016Recall ID: 55638Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels
Additional Source Details
| Field | Value |
|---|---|
| N I D | 55638 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/faslodex-fulvestrant-risk-unnecessary-therapy-modification-due-falsely-elevated |
| Issue | Product safety |
| Title | FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2016-10-18 |
| Organization | Marketed health products |